Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment.
about
Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the LiteratureBotulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of ActionCurrent guidelines in the management of interstitial cystitisSimilarities between interstitial cystitis/bladder pain syndrome and vulvodynia: implications for patient managementReview of intravesical therapies for bladder pain syndrome/interstitial cystitisInterstitial cystitis/painful bladder syndrome: diagnostic evaluation and therapeutic response in a private urogynecology unitA multidisciplinary approach to the evaluation and management of interstitial cystitis/bladder pain syndrome: an ideal model of careNovel research approaches for interstitial cystitis/bladder pain syndrome: thinking beyond the bladderThe enigma of men with interstitial cystitis/bladder pain syndromeTransgenic Mice Expressing MCP-1 by the Urothelium Demonstrate Bladder Hypersensitivity, Pelvic Pain and Voiding Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model StudyAnorectal and Pelvic PainFunctional urological disorders: a sensitized defence response in the bladder-gut-brain axis.Efficacy and safety of botulinum toxin injection for interstitial cystitis/bladder pain syndrome: a systematic review and meta-analysis.Increased Expression of Neuregulin 1 and erbB2 Tyrosine Kinase in the Bladder of Rats With Cyclophosphamide-Induced Interstitial Cystitis.Assessment of colon and bladder crosstalk in an experimental colitis model using contrast-enhanced magnetic resonance imaging.Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study.PK2/PKR1 Signaling Regulates Bladder Function and Sensation in Rats with Cyclophosphamide-Induced CystitisIn what type of interstitial cystitis/bladder pain syndrome is DMSO intravesical instillation therapy effective?A Feasibility Study to Determine Whether Clinical Contrast Enhanced Magnetic Resonance Imaging can Detect Increased Bladder Permeability in Patients with Interstitial Cystitis.Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?Urinary Metabolomics Identifies a Molecular Correlate of Interstitial Cystitis/Bladder Pain Syndrome in a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Cohort.F16357, a novel protease-activated receptor 1 antagonist, improves urodynamic parameters in a rat model of interstitial cystitis.Specific inhibition of ICAM-1 effectively reduces bladder inflammation in a rat model of severe non-bacterial cystitis.Blocking mammalian target of rapamycin alleviates bladder hyperactivity and pain in rats with cystitis.Spinal astrocytic activation contributes to mechanical allodynia in a rat model of cyclophosphamide-induced cystitis.Blocking PAR2 Alleviates Bladder Pain and Hyperactivity via TRPA1 Signal.Important role of physicians in addressing psychological aspects of interstitial cystitis/bladder pain syndrome (IC/BPS): a qualitative analysis.A prospective randomized controlled multicentre trial comparing intravesical DMSO and chondroïtin sulphate 2% for painful bladder syndrome/interstitial cystitisChronic pelvic pain in women: an epidemiological perspective.Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome.Use of botulinum toxin for voiding dysfunction.Expression profile of urothelial transcription factors in bladder biopsies with interstitial cystitis.Anti-vascular endothelial growth factor treatment decreases bladder pain in cyclophosphamide cystitis: a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network animal model study.Dimethyl sulfoxide (DMSO) as intravesical therapy for interstitial cystitis/bladder pain syndrome: A review.Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).Therapeutic Potential of Human Chorionic Gonadotropin Against Painful Bladder Syndrome/Interstitial Cystitis.A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society.The Challenges of Interstitial Cystitis: Current Status and Future Prospects.Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and the efficacy of antimuscarinic treatment.
P2860
Q26749613-CA0CFAE3-F4B9-4BD3-84D2-C79DDCC9B89EQ26750535-6F3EFE4B-44A4-419C-AD88-2EC90E0AFCEAQ26773527-641AD147-C37A-49EA-8453-9F2B86C18980Q26773540-E2E29195-12DD-4D41-84AA-BF315D629C37Q26773549-653A0CE6-AEDD-4798-982B-C6A27D5F9390Q26773559-59CA8CD7-5519-4880-8C97-9D288485EA46Q26773567-7182796E-1440-4C8C-A78B-C1912EC48575Q26774233-C0FF3211-9F3B-4B8E-8172-0F8AE6312501Q26774274-458DBACB-2C76-434F-AC8A-7A679A856F90Q28554395-9CBB26B9-1381-4EC3-9A65-3DE1A5451670Q34542163-1A21F8A0-D686-4A2C-AC00-C51FA18F7A42Q34546729-A3F36909-656A-4EA2-B5F4-E5ABD04BB2B2Q36006813-42900F74-3EAA-4089-9992-2362C4CCD62DQ36090760-09B59B68-55F1-44A9-B682-7B1796ED4D72Q36219843-04DD62BE-4734-466C-95F5-687B175A5023Q36230460-A16019FD-E83A-44F4-9B6D-53691FBE6C80Q36241186-76D267FE-97BF-4353-A9F0-7EA7F2740527Q36427293-D8F5E496-AD63-43AD-B2B2-98FBA1830CCFQ36451079-98F616C9-2DCF-41C7-8DCF-57BE1989F5F8Q36599064-0EB7983B-1F45-412B-A6B6-6FF32E80ECD3Q36735590-43C1747C-C6FE-4A42-8160-5EB0A74D0075Q37008508-D10CC0A2-4C03-4E54-A968-4F612DE8FADDQ37034776-BD5A65DB-6994-4803-9695-297739320F96Q37367004-54EF89E5-EE7A-4FCB-A7DC-A1C9A93591DBQ37375064-205CC9A5-52D7-4BD6-8514-635F223EA066Q37426010-FA62CEBB-94EC-4F8B-AF04-BF301D6E1EE6Q37585440-55EA5F04-7786-4E43-9A7C-594812167BE0Q37624742-1A5266F1-65BE-41CC-801F-F26E4FA6C904Q37626521-020E83B7-4D54-4B81-A733-C4EB6A536D56Q38602766-ACF1271C-A222-4E6F-9272-718B8E5ACD5EQ38674296-A1D6B278-E6C4-4FF8-929A-124294008446Q38679555-A2F40F74-5AAF-4B23-94D4-625FF7FC443AQ38719945-09F81B16-5A99-4EDE-B53C-2A79EB3AAB4FQ38743785-F353A3D5-F64A-4C17-A94F-0E6EF5C2A166Q38755106-BB8EEE90-1624-4F7C-9CF9-43101A7071A5Q38759710-9CA8D41A-EE32-433C-BFFA-F95851C6F215Q38785364-817C054E-AE94-4EEE-92CC-C48A8E8144D2Q38937743-FD7F7850-924B-4F19-A77B-E16B40B1D5C6Q38939006-7D5DD16B-F76A-46D0-BDFD-5B52B2763E78Q40059471-2B349359-F57A-45AE-B19D-9AE3CB5FA50E
P2860
Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Diagnosis and treatment of int ...... rome: AUA guideline amendment.
@ast
Diagnosis and treatment of int ...... rome: AUA guideline amendment.
@en
Diagnosis and treatment of int ...... rome: AUA guideline amendment.
@nl
type
label
Diagnosis and treatment of int ...... rome: AUA guideline amendment.
@ast
Diagnosis and treatment of int ...... rome: AUA guideline amendment.
@en
Diagnosis and treatment of int ...... rome: AUA guideline amendment.
@nl
prefLabel
Diagnosis and treatment of int ...... rome: AUA guideline amendment.
@ast
Diagnosis and treatment of int ...... rome: AUA guideline amendment.
@en
Diagnosis and treatment of int ...... rome: AUA guideline amendment.
@nl
P2093
P1476
Diagnosis and treatment of int ...... rome: AUA guideline amendment.
@en
P2093
American Urological Association
Deborah Erickson
Martha M Faraday
Philip M Hanno
Robert Moldwin
P304
P356
10.1016/J.JURO.2015.01.086
P407
P577
2015-01-23T00:00:00Z